Repligen reported $284.16M in Debt for its third fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Debt Change
Agilent A:US USD 2.77B 143M
Bio Techne TECH:US USD 264.66M 8.75M
Biomarin Pharmaceutical BMRN:US USD 1.08B 986K
Bristol Myers Squibb BMY:US USD 39.32B 222M
Bruker BRKR:US USD 1.15B 31.2M
Catalent CTLT:US USD 4.2B 2M
Charles River Laboratories CRL:US USD 2.94B 60.45M
Danaher DHR:US USD 19.68B 430M
Dentsply International XRAY:US USD 1.98B 44M
Exact Sciences EXAS:US USD 2.25B 2.88M
Fluidigm FLDM:US USD 64.72M 172K
General Electric GE:US USD 32.35B 1.94B
Henry Schein HSIC:US USD 1.05B 187M
Illumina ILMN:US USD 1.74B 1000K
IQVIA Holdings Inc IQV:US USD 12.39B 373M
Mettler Toledo International MTD:US USD 1.98B 50.86M
Nanostring Technologies NSTG:US USD 226.25M 373K
Orasure Technologies OSUR:US USD 2.18M 450K
Pacific Biosciences Of California PACB:US USD 896.53M 155K
Patterson Companies PDCO:US USD 662.52M 28.71M
Peregrine Pharmaceuticals PPHM:US USD 142.44M 134K
Perkinelmer PKI:US USD 4.4B 86.68M
Repligen RGEN:US USD 284.16M 453K
Thermo Fisher Scientific TMO:US USD 34.49B 5.33B
Waters WAT:US USD 1.54B 60.25M
West Pharmaceutical Services WST:US USD 209.4M 42.6M